Gritstone Asset Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,666
Closed -$259K 92
2024
Q4
$259K Buy
+24,666
New +$259K 0.27% 41